A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 21,301 shares of IBRX stock, worth $55,808. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,301
Previous 17,001 25.29%
Holding current value
$55,808
Previous $107,000 26.17%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$3.32 - $6.7 $14,276 - $28,810
4,300 Added 25.29%
21,301 $79,000
Q2 2024

Jul 19, 2024

BUY
$4.82 - $9.15 $7,712 - $14,640
1,600 Added 10.39%
17,001 $107,000
Q1 2024

Apr 22, 2024

BUY
$3.23 - $6.17 $10,319 - $19,713
3,195 Added 26.18%
15,401 $82,000
Q4 2023

Jan 16, 2024

BUY
$1.25 - $5.21 $312 - $1,302
250 Added 2.09%
12,206 $61,000
Q3 2023

Oct 24, 2023

SELL
$1.29 - $3.1 $1,096 - $2,635
-850 Reduced 6.64%
11,956 $20,000
Q2 2023

Jul 25, 2023

SELL
$1.53 - $6.41 $1,695 - $7,102
-1,108 Reduced 7.96%
12,806 $35,000
Q1 2023

Apr 14, 2023

BUY
$1.35 - $4.78 $1,215 - $4,302
900 Added 6.92%
13,914 $25,000
Q4 2022

Feb 08, 2023

SELL
$4.35 - $6.77 $6,524 - $10,155
-1,500 Reduced 10.33%
13,014 $65,000
Q3 2022

Oct 25, 2022

BUY
$3.65 - $6.43 $3,259 - $5,741
893 Added 6.56%
14,514 $72,000
Q2 2022

Aug 12, 2022

BUY
$2.68 - $6.14 $36,504 - $83,632
13,621 New
13,621 $51,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.05B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.